Oxford Biomedica PLC
22 March 2005
Oxford BioMedica plc ('the Company')
Directors' Interest in Shares and Share Options
Oxford BioMedica (OXB:L) The Company today announced that Peter Nolan and Andrew
Wood, both directors of the Company, had exercised options over 227,731 and
262,346 1p ordinary shares respectively. The exercise price was 15p per share.
The options have been exercised now because they were granted on 7 April 1998,
and if not exercised, would otherwise lapse on 7 April 2005. The option shares
are subject to a block listing, so are already listed. Including the shares
allotted on exercise of these options, the total number of the Company's issued
shares is now 374,019,466. Peter Nolan and Andrew Wood have both sold today all
the shares allotted on the exercise of these options at 19 pence per share.
The total interests of Peter Nolan and Andrew Wood in the Company's 1p ordinary
shares and share options following these transactions are:
Shares Share options
-------------------------- --------- -------
Peter Nolan 87,780 883,498
Andrew Wood 128,950 1,242,750
Andrew Wood
Company Secretary, Oxford BioMedica plc
22 March 2005
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.